Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Central nervous effects of Exenatide on regulation of hunger and satiety in obesity and type 2 diabetes
DRKS00000301Phase 2Recruiting
- Sponsor
- Leipzig University
- Start
- Jan 2010
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in obesity and type 2 diabetes mellitus (T2DM) comparing Exenatide i.v with Placebo (0.9% sodium chloride i.v.) (2 arms). Started Jan 2010; status: recruiting.
02
Drugs
exenatide
03
Conditions
obesitytype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on DRKS00000301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000301.